Enovis EBITDA Margin 2010-2025 | ENOV

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Enovis (ENOV) over the last 10 years. The current EBITDA margin for Enovis as of June 30, 2025 is .
Enovis EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-06-30 $2.19B $0.18B 8.17%
2025-03-31 $2.15B $0.15B 6.79%
2024-12-31 $2.11B $0.16B 7.55%
2024-09-30 $2.00B $0.15B 7.50%
2024-06-30 $1.91B $0.15B 7.63%
2024-03-31 $1.82B $0.16B 8.97%
2023-12-31 $1.71B $0.15B 8.90%
2023-09-30 $1.66B $0.13B 7.52%
2023-06-30 $1.63B $0.12B 7.49%
2023-03-31 $1.59B $0.14B 8.78%
2022-12-31 $1.56B $0.15B 9.47%
2022-09-30 $0.99B $0.09B 9.34%
2022-06-30 $0.96B $0.11B 11.76%
2022-03-31 $0.92B $0.11B 12.15%
2021-12-31 $1.43B $0.20B 14.10%
2021-09-30 $0.47B $0.13B 27.06%
2021-06-30 $0.92B $0.20B 21.55%
2021-03-31 $1.18B $0.20B 16.82%
2020-12-31 $1.12B $0.18B 16.07%
2020-09-30 $3.13B $0.42B 13.48%
2020-06-30 $3.17B $0.44B 13.78%
2020-03-31 $3.46B $0.50B 14.36%
2019-12-31 $3.33B $0.44B 13.19%
2019-09-30 $2.67B $0.35B 13.09%
2019-06-30 $2.34B $0.29B 12.16%
2019-03-31 $2.00B $0.25B 12.42%
2018-12-31 $2.19B $0.30B 13.68%
2018-09-30 $1.48B $0.40B 26.95%
2018-06-30 $1.80B $0.43B 24.03%
2018-03-31 $2.09B $0.46B 22.01%
2017-12-31 $1.94B $0.45B 23.32%
2017-09-30 $3.01B $0.40B 13.28%
2017-06-30 $2.93B $0.38B 13.09%
2017-03-31 $3.04B $0.39B 12.68%
2016-12-31 $3.19B $0.38B 11.93%
2016-09-30 $3.13B $0.38B 12.04%
2016-06-30 $3.33B $0.37B 11.10%
2016-03-31 $3.40B $0.39B 11.53%
2015-12-31 $3.43B $0.42B 12.23%
2015-09-30 $4.11B $0.48B 11.75%
2015-06-30 $4.31B $0.56B 13.01%
2015-03-31 $4.48B $0.58B 12.95%
2014-12-31 $4.62B $0.59B 12.65%
2014-09-30 $4.59B $0.58B 12.73%
2014-06-30 $4.44B $0.56B 12.53%
2014-03-31 $4.31B $0.54B 12.56%
2013-12-31 $4.21B $0.53B 12.48%
2013-09-30 $4.06B $0.46B 11.25%
2013-06-30 $4.00B $0.42B 10.52%
2013-03-31 $3.97B $0.39B 9.76%
2012-12-31 $3.91B $0.32B 8.28%
2012-09-30 $3.06B $0.24B 7.73%
2012-06-30 $2.28B $0.15B 6.58%
2012-03-31 $1.42B $0.07B 4.93%
2011-12-31 $0.69B $0.05B 7.06%
2011-09-30 $0.68B $0.08B 11.27%
2011-06-30 $0.65B $0.08B 12.25%
2011-03-31 $0.58B $0.06B 11.02%
2010-12-31 $0.54B $0.05B 9.59%
2010-09-30 $0.51B $0.04B 8.10%
2010-06-30 $0.50B $0.04B 8.35%
2010-03-31 $0.51B $0.05B 8.84%
2009-12-31 $0.53B $0.06B 10.67%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.797B $2.108B
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.530B 60.47
Tempus AI (TEM) United States $13.989B 0.00
Doximity (DOCS) United States $12.688B 56.45
Hims & Hers Health (HIMS) United States $10.074B 82.54
IRhythm Technologies (IRTC) United States $5.433B 0.00
Hinge Health (HNGE) United States $4.516B 0.00
Inspire Medical Systems (INSP) United States $2.839B 41.74
Privia Health (PRVA) United States $2.699B 199.91
Heartflow (HTFL) $2.367B 0.00
10x Genomics (TXG) United States $1.780B 0.00
Phreesia (PHR) United States $1.770B 0.00
Omnicell (OMCL) United States $1.544B 29.75
Schrodinger (SDGR) United States $1.495B 0.00
Azenta (AZTA) United States $1.446B 63.10
Clover Health Investments (CLOV) United States $1.399B 0.00
Claritev (CTEV) United States $1.189B 0.00
Evolent Health (EVH) United States $1.128B 0.00
Fulgent Genetics (FLGT) United States $0.666B 0.00
Zepp Health (ZEPP) Netherlands $0.580B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Standard BioTools (LAB) United States $0.485B 0.00
Talkspace (TALK) United States $0.469B 140.00
Butterfly Network (BFLY) United States $0.383B 0.00
Carlsmed (CARL) United States $0.346B 0.00
TruBridge (TBRG) United States $0.307B 53.90
Outset Medical (OM) United States $0.252B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.244B 0.00
Health Catalyst (HCAT) United States $0.231B 0.00
Nyxoah SA (NYXH) Belgium $0.219B 0.00
KORU Medical Systems (KRMD) United States $0.203B 0.00
CapsoVision (CV) United States $0.187B 0.00
MDxHealth SA (MDXH) Belgium $0.156B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.148B 0.00
CareCloud (CCLD) United States $0.120B 5.44
American Well (AMWL) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.074B 0.00
Pulmonx (LUNG) United States $0.069B 0.00
111 (YI) China $0.060B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Precipio (PRPO) United States $0.023B 0.00
Zhongchao (ZCMD) China $0.022B 0.00
Healthcare Triangle (HCTI) United States $0.017B 0.00
PROFUSA (PFSA) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.005B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00